Long-read sequencing is transforming neurodegenerative disease research by enabling the detection of complex genetic variants such as structural variations, repeat expansions, and epigenetic features.

In this webinar, Target ALS will share why they chose PacBio HiFi sequencing for sequencing up to 6,000 genomes in the largest ALS genomics study to date. Learn how HiFi long-read data is revealing hidden variants missed by short reads—and how open access to this data is accelerating global ALS research.

• Gain insight into the goals, scope, and scientific potential of the largest long-read ALS genomics initiative to date.
• Learn how PacBio HiFi sequencing was selected for its unique ability to detect complex variants — critical for advancing ALS research.
• Discover solutions that deliver the accuracy, throughput, and scalability required for population-scale studies.